Gilead's China Remdesivir Patents Confirmed, Generics Firms Cautioned
US Firm Gains Upper Hand Amid Patent Dispute
As the front-runner antiviral in the fight against the coronavirus gets increasingly positive attention in China, officials take action to keep the originator front and center and domestic copycats at bay.
